WallStreetZenWallStreetZen

NASDAQ: HOLX
Hologic Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

HOLX past earnings growth

How has HOLX's earnings growth performed historically?
Company
-46.46%
Industry
27.17%
Market
61.16%
HOLX's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
HOLX's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Market Performance

HOLX past revenue growth

How has HOLX's revenue growth performed historically?
Company
-11.12%
Industry
7.75%
Market
16.96%
HOLX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
HOLX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
HOLX's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

HOLX earnings and revenue history

Current Revenue
$4.0B
Current Earnings
$515.1M
Current Profit Margin
13%

HOLX Return on Equity

Current Company
10.2%
Current Industry
11.1%
Current Market
188%
HOLX's Return on Equity (10.2%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when HOLX announces earnings.

HOLX Return on Assets

Current Company
5.7%
Current Industry
7.2%
HOLX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

HOLX Return on Capital Employed

Current Company
9.74%
Current Industry
9.7%
HOLX's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

HOLX vs Medical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
HOLX$3.97B$1.06B$515.10M+4.03%+60.43%
COO$3.67B$934.70M$290.80M+7.36%-4.63%
BAX$14.81B$4.33B$2.66B+5.94%+12.60%
TFX$2.97B$759.97M$356.33M+3.97%+11.54%
RGEN$638.76M$134.17M$41.58M+26.91%+14.57%
View Top Medical Stocks

HOLX earnings dates

Next earnings date
May 2, 2024

Hologic Earnings & Revenue FAQ

What were HOLX's earnings last quarter?

On Invalid Date, Hologic (NASDAQ: HOLX) reported Q4 2023 earnings per share (EPS) of $1.03, up 35.53% year over year. Total Hologic earnings for the quarter were $246.50 million. In the same quarter last year, Hologic's earnings per share (EPS) was $0.76.

If you're new to stock investing, here's how to buy Hologic stock.

What was HOLX's earnings growth in the past year?

As of Q2 2024, Hologic's earnings has grown -46.46% year over year. This is 73.63 percentage points lower than the US Medical Instruments & Supplies industry earnings growth rate of 27.17%. Hologic's earnings in the past year totalled $515.10 million.

What is HOLX's earnings date?

Hologic's earnings date is Invalid Date. Add HOLX to your watchlist to be reminded of HOLX's next earnings announcement.

What was HOLX's revenue last quarter?

On Invalid Date, Hologic (NASDAQ: HOLX) reported Q4 2023 revenue of $1.01 billion up 5.69% year over year. In the same quarter last year, Hologic's revenue was $1.07 billion.

What was HOLX's revenue growth in the past year?

As of Q2 2024, Hologic's revenue has grown -11.12% year over year. This is 18.87 percentage points lower than the US Medical Instruments & Supplies industry revenue growth rate of 7.75%. Hologic's revenue in the past year totalled $3.97 billion.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.